on behal(ofa working group* established by the European Office of the World Health Organisation, Copenhagen ABSTRACT The value of non-invasive procedures for predicting pulmonary arterial pressure was investigated in 370 patients with chronic obstructive lung diseases and in 73 with fibrosing alveolitis in a combined study at nine centres in six European countries. Measurements included forced expiratory volume in one second, arterial blood gas tensions, standard electrocardiogram, radiographic dimensions ofpulmonary artery, right ventricle dimensions by M mode echocardiography, and myocardial scintigraphy with thallium-201; and certain clinical signs were also used. No single variable was correlated closely enough to allow accurate prediction of pulmonary arterial pressure. Four methods were used to incorporate several variables into mathematical functions for predicting pulmonary arterial pressure. In patients with chronic obstructive lung disease multiple stepwise regression explained 49% of the variance in pulmonary arterial pressure but was not useful for prediction. Discriminant analysis allowed patients to be allocated to bands of pulmonary arterial pressure, as did two non-parametric procedures, in which decision trees were established using either the Kolmogoroff-Smirnoff statistic or Fisher's exact test. Patients with a pulmonary arterial pressure of 30 mm Hg or more were identified with a sensitivity of 83% and a specificity of 91%. The nonparametric tests gave better results than discriminant function. A further 54 patients were studied to validate the functions. Of these, 90% with a pulmonary arterial pressure above 20 mm Hg were correctly identified, and 80% of those with a pulmonary arterial pressure above 29 mm Hg. Similar results were obtained in subjects with fibrosing alveolitis. These mathematical functions allow the use of combinations of non-invasive procedures to select from populations at risk of pulmonary hypertension those in whom direct measurement is required. The mathematical functions are capable of further development by incorporation of variables from newer non-invasive procedures.
Introduction
Although the occurrence of pulmonary arterial hypertension is well recognised in various forms of chronic respiratory disease, more information is needed on many aspects of the problem. The prevalence of 86 some workers have explored the possibility that combining the results of several measurements might give a more accurate and specific prediction. Since the early study of Enson et al' there has been intermittent interest in the possibility of predicting pulmonary arterial pressure from other physiological variables. These authors determined the relation between pulmonary arterial pressure and arterial oxygen saturation (Sao2) and arterial pH, but the scatter about the regression was large and the precision with which pulmonary arterial pressure could be predicted was low. This finding was repeated by others.2 All showed that the highest correlation was with arterial oxygen saturation, but this explained less than half of the variance of pulmonary arterial pressure. The addition of other variables to the analysis produced little improvement. In the World Health Organisation multicentre study we reported5 the largest series of patients with chronic obstructive lung disease, and again Sao2 alone explained only 42% ofthe variance of pulmonary arterial pressure, packed cell volume and forced expiratory volume in one second (FEV,) explaining only a further 2%.
Attention began to turn towards the use of other relatively non-invasive measurements, alone or in combination with blood gas values and results ofother pulmonary function tests. Some of these studies tried to predict the value of pulmonary arterial pressure while others sought to diagnose the presence or absence of pulmonary arterial hypertension. Tartulier et al6 followed the latter approach and in a study of43 patients with chronic obstructive lung disease were able to categorise patients accurately using a combination of arterial oxygen tension (Pao2) and the electrocardiogram (ECG) or vectorcardiogram. Evers and Liehs7 studied 372 patients with chronic obstructive lung disease and used a linear discriminant analysis with nine variables derived from pulmonary function tests and measurements of pulmonary arterial diameter on a chest radiograph. The discriminant function allowed the correct identification of 79% of the patients with pulmonary hypertension in a new series. Keller et al8 studied 89 patients with chronic obstructive lung disease and by stepwise linear regression analysis found it possible to explain 60% of the variance of pulmonary arterial pressure, using Pao2, Paco2, and the diameter ofthe right descending branch of the pulmonary artery. Most recently OswaldMammosser et al9 investigated the sensitivity of variables singly and in combination for identifying the presence of pulmonary arterial hypertension in 63 patients with chronic obstructive lung disease and found that combinations always gave better results. With stepwise regression it was possible to account for only 43% of the total variance.
It may be concluded that no single non-invasive Bishop, Csukas procedure allows prediction of the presence of pulmonary arterial hypertension or the level of pulmonary arterial pressure with a sufficient degree of reliability to be of value clinically. Combinations of non-invasive measurements allow prediction of the presence of pulmonary arterial hypertension with satisfactory probability, but the precise level of pulmonary arterial pressure cannot be predicted with sufficient accuracy to be useful. Some of the newer techniques, including Doppler flow measurements and two dimensional echocardiography, show greater promise but it still seems unlikely that any of them used alone will make it necessary to alter these conclusions.
In the present study we have extended previous approaches by using combinations of measurements and some newer statistical and mathematical methods, and have applied them to a larger collection of new data than has been available to earlier workers. The three important characteristics of the study are: (a) it uses only those non-invasive methods which were available in all of the participating centres at the time when the study started in 1978, and which at that time were considered likely to prove useful; (b) it uses various statistical methods, some non-parametric, in an attempt to find the most effective way of utilising the results of the non-invasive measurements; (c) the patients studied are from two diagnostic groups and the predictive values of the measurements in the two groups are compared.
Methods

SELECTION OF PATIENTS
The centres in the study were Brussels, Budapest, Lyons, Milan, Nancy, Prague, Strasbourg, and Warsaw. Patients aged 20-65 years with one of two diagnoses were recruited. Chronic obstructive lung disease Patients had to have either chronic bronchitis, characterised by cough and sputum for at least three consecutive months for each of two consecutive years, or emphysema, characterised by dyspnoea with radiological evidence of emphysema. Both groups had to have functional evidence ofairways obstruction (FEV,/FVC < 55%). Fibrosing alveolitis This was defined by restrictive changes with increased elastic recoil, either caused by exogenous factors or of unknown origin. The diagnosis was made radiologically and on the basis of functional changes, including decreased vital capacity, transfer factor for carbon monoxide, and static compliance, without features of airways obstruction.
Patients were excluded if they had kyphoscoliosis, past thoracic surgery, pneumothorax present or past, asthma at time of study, systemic hypertension (under treatment or diastolic pressure > 105 mm Hg), Combined use ofnon-invasive techniques to predict pulmonary arterialpressure in chronic respiratory disease 87 rheumatic or congenital heart disease, a history of myocardial infarction or angina, pulmonary infection within the last three months, pulmonary embolism or infarction within the last month, pronounced obesity (Broca index > 120%) or other serious disease.
It was intended that the selection should provide patients with pulmonary arterial pressures ranging from normal to substantially raised. In the event 45% ofthe patients had a pulmonary arterial mean pressure below 20 mm Hg, 31% in the range 20-29 mm Hg, and 24% of 30 mm Hg or more. Results of the noninvasive measurements were not available at the time of selection.
The patients were chosen from those attending the centres taking part in the study. As the special interests of these centres varied, and did not in all cases include the full range of respiratory disease, the proportion of patients in the two diagnostic groups varied between centres. The patients studied were therefore a selected sample, chosen to facilitate the study of the relation between certain non-invasive measurements and the level of pulmonary arterial pressure. Because of the way the sample was drawn the results do not define the frequency distribution of levels of pulmonary arterial pressure in a population of patients with any of the stated diagnoses.
An additional group of patients with thromboembolic lung disease was studied simultaneously by identical methods and the results will be reported separately.
The total number of patients studied was 370-297 with chronic obstructive lung disease and 73 with fibrosing alveolitis. After 14 days.
The following procedures were attempted in each patient (obligatory measurements): 12 lead electrocardiography; M mode echocardiography; radiography of chest; recording of forced expiratory spirogram; arterial blood gas tensions and pH; haemoglobin concentration and packed cell volume.
Other non-invasive procedures were optional as they were available in only a few centres-for example, myocardial scintigraphy using thallium-201 .'°Other methods proved to have little diagnostic value or were technically unsatisfactory. These procedures, the results of which were not used in the analysis but have been described elsewhere, included precordial mechanocardiography," measurement of orthostatic variation in transfer factor for carbon monoxide, ' Combined use ofnon-invasive techniques to predict pulmonary arterial pressure in chronic respiratory disease 89 any degree of thallium uptake by right ventricular myocardium (RVWIM). The patients were divided into three categories according to their pulmonary arterial presure. The categories were 19 mm Hg or less, 20 to 29 mm Hg, and 30 mm Hg or more. From the variables measured those that showed substantial differences in mean values between the three pulmonary artery pressure categories were selected. The use of several data sets was necessary because of missing items.
For patients with chronic obstructive lung disease the following four data sets were used: The first set comprised the results of the obligatory measurements listed above, excluding those derived from echocardiography. The variables and their abbreviations are shown in table 1. There were 20 variables and 263 patients. The second set consisted of the variables in the first set together with three additional variables (intrinsicoid deflection VI (IDV 1), pulmonary arterial diameter (PAD) and total lung capacity (TLC)), and six discrete variables (NECK VEINS, LIVER, PAST HISTORY, NEGT-WAVE, STTDEP, and RBBB). This was the largest and most comprehensive data set, consisting of 29 variables. There were 129 patients. The third set consisted of the continuous variables in the second set, plus two variables from the echocardiogram (RvwDIAS and RVDC). There were 25 variables and 86 patients. Thefourth set consisted of the variables in the third set with the addition of the discrete variable for the presence or absence of a right ventricular image on the scintigram (RVWIM). There were 26 variables and 70 patients.
For the patients with fibrosing alveolitis the following two data sets were used: The first set consisted of the continuous variables measured in most patients, excluding any derived from chest radiography or echocardiography. There were 14 variables, indicated in table 4 (with abbreviations), and 69 patients. The second set comprised the variables in the first set together with three from the echocardiogram (RVDC, DEPTHA, and PEP) and one discrete variable (LIVER). There were 18 variables and 35 patients.
DATA ANALYSIS
The following methods were used: Regression analysis Multiple stepwise regression analysis was performed using the methods of the BMDP Statistical Software (University of California at Los Angeles, 1981). The results were used to predict the numerical value of pulmonary arterial pressure (the results of the other procedures are used to put the patients into one of the pulmonary arterial pressure categories).
Discriminant analysis Linear discriminant analysis was used to divide the patients into two categories (appendix). Non-parametric decision procedures A fuller description of these is provided in the appendix. The first is based on the Kolmogoroff-Smirnoff statistic""'9 and divides the population into two parts at a cutting point. The second' uses Fisher's exact test23 to select the variables to be used, the order in which they are to be used, and the cutting point. The population is divided into three categories in a two stage procedure. After completion of the first stage all the remaining members of the population are used in the second stage.
The effectiveness of these procedures has been judged in terms of sensitivity and specificity. The former is a measure of the ability of the test to place all individuals in the population studied who have the defined characteristic correctly-that is, within a particular pulmonary arterial pressure category. It is estimated as the proportion of true positives correctly placed. Specificity is a measure of the effectiveness of the test in selecting only those individuals who truly fall within a category without selecting others who do not. It is estimated as the proportion of true negatives correctly placed.
Results
The two diagnostic groups are considered separately.
CHRONIC OBSTRUCTIVE LUNG DISEASE Table 1 gives the mean values and standard deviations of the variables with correlation coefficients for individual variables and pulmonary arterial pressures. This ranged from 6 to 62 mm Hg, with a mean of 23-4 (SD 9 8) and a median of 21. The distribution of pulmonary arterial pressures was skewed and the objective ofobtaining an even spread ofvalues was not fully achieved as only 22% of values were 30 mm Hg or greater.
Stepwise regression was performed for each data set. There was no "centre effect," indicating that there was no systematic difference between centres in measuring pulmonary artery pressure.
By using the first set (table 2) it was possible to explain 34% of the variance in pulmonary artery pressure values. By using the second set 44% of the variance of pulmonary artery pressure was explained by six variables, of which four were continuous and two discrete. The order in which these variables entered the regression equation (table 2) was: negati ie T wave in VI, pulmonary arterial diameter, vital capacity, enlarged liver, maximum P wave height, and arterial pH.
Analysis of the third data set allowed 49% of the (second time), and FEV,). The sensitivity was 94% and the specificity 77%. Discussion
In a multicentrre study in several countries there will always be difficulties in maintaining consistency in the procedures and methods used. Uniform definitions were used but the technical methods were not identical in all centres. All methods were thoroughly tested and in regular use, and when it was feasible records were referred to one centre for confirmatory measurement. We therefore feel confident that no systematic errors were introduced into the data because of their multicentre origin. Selection of patients for the study differed between centres and this has resulted in differences in the mean values for some variables. This was not unexpected and there is no reason to believe that it has influenced the conclusions of the analysis.
The technical methods selected for study were those available at the time the investigation started, which were thought to be possibly useful for the non-invasive diagnosis of pulmonary arterial hypertension. The variables finally used in the analysis were derived mainly from the ECG, chest radiograph, arterial blood gas analysis, and FEVY. Measurements from M mode echocardiography were used in fibrosing alveolitis, but an insufficient number were obtained from patients with chronic obstructive lung disease to be useful. Myocardial scintigraphy with thallium-201 might have contributed had it been available for a larger number of patients.
Several methods were discarded early in the investigation. The orthostatic variation in transfer factor for carbon monoxide,'2 which had proved valuable in patients with mitral valve disease, was of no use in patients with pulmonary hypertension not associated with a raised pulmonary venous pressure. For the same reason perfusion scanning of the lung'3 had no diagnostic utility. It was technically difficult to standardise both the recording and the subsequent measurement of precordial mechanocardiographic tDoes not differ significantly from zero. traces." The vectorcardiogram, available in only a few approach. When stepwise regression analysis was used centres, appeared to have no advantage over the in this way the results were similar to those reported conventional ECG.'4 Measurements of static lung previously. The regression equations explained 44% volumes, airways resistance, lung compliance, and of the variance in pulmonary arterial pressure. The transfer factor were available in a small proportion of value in fibrosing alveolitis was higher at 56% but this the patients studied, and were found to have no was based on a smaller number of patients and is predictive value. probably less reliable. As a means of prediction the The correlation coefficients between pulmonary margin of uncertainty was too large for the method to arterial pressure and individual variables were statis-be of practical use. It may be possible in the future, tically significant, but only a small part of the variance with newer methods, to improve the accuracy of in pulmonary arterial pressure was explained in each prediction, but for the present analysis we have case and consequently the variable was of no use as a concentrated on using the data to place an individual predictor of pulmonary arterial pressure. The large into one or other pulmonary arterial pressure category size of the data set permitted further analysis, includ-rather than attempt to predict the actual pressure. ing some mathematical procedures less often used for Discriminant analysis gave results with a sensitivity this purpose.
of up to 80% in chronic obstructive lung disease, and If it had proved possible to use the non-invasive with values rather higher in fibrosing alveolitis. The measurements to predict the numerical value of pul-non-parametric procedures allowed greater flexibility. monary arterial pressure with sufficient precision to be That based on the Kolmogoroff-Smirnoff statistic practically useful this would have been the preferred generally gave results similar to those ofthe discrimin- Table 5 Results ofstepwise regression analysis using two data sets in patients with diffusefibrosing alveolitis group.bmj.com on April 15, 2017 -Published by http://thorax.bmj.com/ Downloaded from ant analysis. The second, based on Fisher's exact test, gave rather better results with sensitivity around 90%. It was especially effective in selecting patients with high pulmonary arterial pressure.
The measurements used to validate the derived functions showed that discriminant function analysis was the least satisfactory method for categorising the newly studied patients. The other methods were about equally reliable in placing the patients in the correct category and had a sensitivity of about 90% in detecting the presence of pulmonary hypertension. Unfortunately some data were missing and in consequence the derived functions performed less well than they might have done with complete data.
The procedures could be used to screen a population of patients to select those likely to have pulmonary hypertension, who would then undergo cardiac catheterisation. There is a need for a procedure that will reliably select a very high proportion of those with pulmonary arterial hypertension (high sensitivity) and will include only a small number of those with normal pulmonary arterial pressure (high specificity).
Discriminant function analysis has little to offer for this purpose. The non-parametric procedures performed better, and they allow the incorporation of discrete variables, which is sometimes useful. They also permit variables to be selected, their order determined, and the cutting point decided. With experience it may well prove possible to select these to maximise the sensitivity and specificity, and to "tailor" the functions to meet special requirements.
Since the investigation began some promising new methods have become available. With two dimensional echocardiography records may be obtainable in a larger proportion of patients with chronic obstructive lung disease than with M mode echocardiography, and the measurements may be more accurate. In this case measurement of right ventricle cavity dimensions and wall thickness may prove useful. Measurement of blood flow using Doppler echocardiography has yet to be thoroughly explored in chronic respiratory disease.
In this study we have concentrated on predicting the presence and degree of pulmonary arterial hypertension. Some but not all of the measured variables are thought to reflect aspects of right ventricular structure and function. Although pulmonary arterial hypertension, right ventricular hypertrophy, and subsequently right ventricular failure are closely related, we need to understand more about the time course ofthe progression from one to the other-whether, for example, pulmonary arterial hypertension can be identified at an early stage before right ventricular hypertrophy has developed.
Our results confirm that no single variable that we tested provides a non-invasive procedure capable of measuring pulmonary arterial pressure sufficiently Bishop, Csukas accurately to be useful. We have shown the potential of mathematical functions that combine the results from simple, readily available, and relatively cheap methods for detecting pulmonary hypertension. We have described how these functions can be used in their present form by anyone interested in screening a population of individuals at risk of pulmonary hypertension. Possible populations for screening could include patients with chronic bronchitis, an occupational group, and patients taking a particular drug.
We have described how the mathematical functions have been derived and we emphasise that as other noninvasive methods become available the results can be incorporated into new functions, whose value can be tested. It will also be possible to refine the functions further, and to adjust the specificity and sensitivity according to the requirements of a particular investigation.
Appendix
We wished to classify subjects into one of three groups according to their pulmonary arterial pressure by means of other, so called explanatory, variables provided by the results ofa series of non-invasive diagnostic tests. This problem may be approached by different methods, including linear discriminant analysis, which assumes a normal distribution of the values of the explanatory variables, and non-parametric methods, where no such assumption is required. The latter also permit the use of discrete (non-continuous) variables. We provide here a briefdescription ofthe procedures we have used and a demonstration of their application. The Kolmogoroff-Smirnoff (K-S) statistic'7'9 is the maximum value of the difference between the empirical distributions of random variables drawn from two samples. We have used the K-S statistic to separate patients into two groups according to their pulmonary arterial pressure. The value ofa given explanatory variable at which the maximum difference was reached was used as a cutting point to classify patients according to this grouping.
We have applied the method in a stepwise way, and to illustrate the procedure we describe here (fig 1) the subdivision ofpatients with chronic obstructive lung disease into the groups PAP > 30 and PAP (29. Firstly, the variable for which the K-S statistic is maximal is selected; in this example it is SWAvEDI, and the cutting point is 1. At the second step the same procedure has been used separately for the two groups obtained at the first step. For the group in whom SWAvEDI is <1 the K-S statistic was maximal for pulmonary arterial diameter (PAD), with a cutting point of 20. For the other group obtained at the first step, in whom swAvEDI is > 1, the appropriate variable at the second stage was Pco2 with a cutting value of 47 mm Hg (6-3 kPa).
The stepwise application of the K-S statistic enables the rate of misclassification to be progressively diminished. In practice we found that there was no further improvement after two or three steps. Patients for whom a value for the variable required at a particular stage was missing were eliminated at that stage. Figures 1 and 2 (29) . If the probability of the allocation to group I exceeds a predetermined value then the patient is finally classified in group I (labelled F). For the remainder a new variable and threshold are selected in the same way and the process repeated. If a value is missing at any step the patient is classified in the group not under selection (group 2). The number of steps is variable and may be limited to a preset number, or when further variables fail to classify more patients to F. It will be evident that in the most extreme case a patient with a true PAP > 30 might be classified to the group PAP (19. Such misclassification occurred in only two patients.
